By Denny Jacob

Abbott Laboratories said Friday that it is releasing limited quantities of metabolic nutrition formulas that were previously on hold at the request of the Food and Drug Administration.

The company said the formulas were previously on hold following its recall of some powder infant formulas from its Sturgis, Mich., facility.

The company said the products being released weren't included in the recall. It added that the products have been tested and comply with all product release requirements before distribution.

Abbott said it has implemented corrective actions and is working with the FDA to address the situation before resuming operations at its facility. It said it will take at least six to eight weeks for products to be available for distribution once it can resume production.

Write to Denny Jacob at denny.jacob@wsj.com

(END) Dow Jones Newswires

April 29, 2022 17:10 ET (21:10 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Abbott Laboratories.
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Abbott Laboratories.